Viewing Study NCT00148135


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2026-06-29 @ 8:12 PM
Study NCT ID: NCT00148135
Status: TERMINATED
Last Update Posted: 2008-01-10
First Post: 2005-09-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UMCC 2001-021
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View